The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The association of sociodemographic variables with smoking prevalence in patients enrolled on clinical trials.
 
Cary A. Presant
Stock and Other Ownership Interests - Cancer Diagnostics of America
Patents, Royalties, Other Intellectual Property - Patent pending for "A Method and Devices for Direct Apoptosis of Purified Cells"
(OPTIONAL) Uncompensated Relationships - Cancer Diagnostics of America
 
Riha Vaidya
No Relationships to Disclose
 
Cathee Till
Research Funding - MustangBio (I)
Patents, Royalties, Other Intellectual Property - Patent for CD20-targeted CAR T cells. (I)
 
Kimlin Tan Ashing
Honoraria - AstraZeneca
Consulting or Advisory Role - Anthem
 
Graham W. Warren
Patents, Royalties, Other Intellectual Property - patent or royalties associated with a radioprotective compound; Patent pending for radioprotective compound (Inst)
Other Relationship - non-profit organizations
 
Dawn L. Hershman
Consulting or Advisory Role - AIM Specialty Health
 
Virginia Sun
No Relationships to Disclose
 
Shanmugga Subbiah
No Relationships to Disclose
 
Ravi Salgia
Consulting or Advisory Role - Abbvie; AstraZeneca; Iovance Biotherapeutics; Novartis
Speakers' Bureau - AstraZeneca; DAVA Oncology; Merck
 
Erminia Massarelli
Honoraria - AstraZeneca; Merck
Consulting or Advisory Role - Abbvie; Bristol Myers Squibb Foundation; Daiichi Sankyo Co.; Genentech/Roche; Janssen Scientific Affairs; Lilly; Merck; Sanofi
Speakers' Bureau - AstraZeneca; Lilly; Merck; Mirati Therapeutics; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Merck (Inst); Pfizer (Inst); Tessa Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Pfizer
 
Joanne E. Mortimer
Consulting or Advisory Role - GlaxoSmithKline; Novartis; Pfizer; Puma Biotechnology
 
Marwan Fakih
Honoraria - Amgen
Consulting or Advisory Role - Amgen; Bayer; BMS; Eisai; GlaxoSmithKline; Incyte; Merck; Mirati Therapeutics; Nouscom; Pfizer; Roche/Genentech; Seagen; Taiho Pharmaceutical
Speakers' Bureau - Guardant Health
Research Funding - Amgen (Inst); Verastem (Inst)
 
Sumanta Kumar Pal
Travel, Accommodations, Expenses - crispr therapeutics; Roche
 
Arya Amini
Speakers' Bureau - AstraZeneca; Takeda
Research Funding - Genentech
 
Loretta Erhunmwunsee
No Relationships to Disclose
 
Tanyanika Phillips
No Relationships to Disclose
 
Steven T. Rosen
Stock and Other Ownership Interests - January Therapeutics; Pepromene
Honoraria - Celgene
Consulting or Advisory Role - Abbvie; Pepromene
Speakers' Bureau - Abbvie
Research Funding - Celgene
 
Joseph M. Unger
No Relationships to Disclose